✦ LIBER ✦

Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing–remitting multiple sclerosis

✍ Scribed by Roland Martin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-CD25 Antibody (Daclizumab) Maintena

✍ V.A. Kirchner; T.M. Suszynski; D.M. Radosevich; A. Humar; T.B. Dunn; M.J. Hill; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Anti-CD20 monoclonal antibody therapy in

✍ Prashant Kapoor; Patricia T. Greipp; William G. Morice; S. Vincent Rajkumar; Tho 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

Clinical significance of antibodies to i

✍ Klaus Bendtzen 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Clinical course after change of immunomo

✍ C. Caon; M. Din; W. Ching; A. Tselis; R. Lisak; O. Khan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

Anti-CD20 monoclonal antibody therapy in

✍ Holger Nückel; Daniel Meller; Klaus-Peter Steuhl; Ulrich Dührsen 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

OR.33. CD127-depleted CD4+CD25high Regul

✍ Laure Michel; Laureline Berthelot; Ségolène Pettré; Sandrine Wiertlewski; Fabien 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 38 KB